SMARCB1 and neoplasm: In Case 7, SMARCB1 and FANCA variants were detected in the majority of cells (62–92%) in both regions; however, the VAF of an ATR variant (0.28 and 0.13 in Regions A and B, respectively) indicated that this was a later event in the development of this tumour.